Arterial hypertension is associated with an increased risk of metabolic complications in pediatric patient with obesity

J Pediatr Endocrinol Metab. 2022 Jun 30;35(8):1028-1032. doi: 10.1515/jpem-2022-0205. Print 2022 Aug 26.

Abstract

Objectives: Coexistence of arterial hypertension (AH) in children with obesity increases morbidity and shortens life. Its role as an indicator of coexisting metabolic complications is however less known. The objective of the study was to compare metabolic profiles of children with obesity and with or without AH.

Methods: We included patients aged 10-18 with the BMI Z-score ≥2. Diagnosis of AH was based on the European Society of Hypertension criteria (2016). Metabolic profiles were assessed by glucose and insulin levels taken before and after glucose load, fasting levels of triglycerides (TG), total (TC), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, and HOMA-IR.

Results: Of 534 patients, 33.5% were diagnosed with AH. The AH patients, as compared to non-AH, had higher fasting insulin levels (22 vs. 19.7 mIU/L, p=0.04), HOMA-IR (4.5 vs. 4.0, p=0.029), and post-load glucose level (6.3 vs. 5.7, p=0.000041). No differences in the post-load insulin levels (113 vs. 100 mIU/L, p=0.056), fasting glucose (4.5 vs. 4.5 mmol/L, p=0.5), or lipids were found (TC: 4.4 vs. 4.4 mmol/L, p=0.9; LDL: 2.7 vs. 2.7, p=0.2; TG: 1.4 vs. 1.4 mmol/L, p=0.5; HDL: 1.1 vs. 1.2, p=0.3.

Conclusions: Concomitance of AH in children with obesity may be an indicator of coexisting metabolic complications.

Keywords: adolescent; insulin resistance; metabolic syndrome.

MeSH terms

  • Blood Glucose / metabolism
  • Body Mass Index
  • Child
  • Cholesterol, HDL
  • Glucose
  • Humans
  • Hypertension* / complications
  • Insulin Resistance*
  • Insulins*
  • Obesity / complications
  • Obesity / metabolism
  • Triglycerides

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Insulins
  • Triglycerides
  • Glucose